➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Dow
Mallinckrodt
Moodys
McKesson

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Patent: 9,395,364

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,395,364
Title:Biomarkers for inflammatory bowel disease with ankylosing spondylitis
Abstract: There is provided herein a method for categorizing a patient having inflammatory bowel disease as being at risk for developing ankylosing spondylitis. The method comprises the use of a patient level of auto-antibodies directed against noggin (NOG) and/or sclerostin (SOST) to determine a risk for the patient developing ankylosing spondylitis. There is also provided methods of monitoring ankylosing spondylitis treatment using these auto-antibodies.
Inventor(s): Tsui; Florence Wing Ling (Oakville, CA), Inman; Robert Davies (Toronto, CA)
Assignee: UNIVERSITY HEALTH NETWORK (Toronto, CA)
Application Number:14/764,492
Patent Claims:see list of patent claims

Details for Patent 9,395,364

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Janssen Biotech SIMPONI ARIA golimumab INJECTABLE; INJECTION 125433 001 2013-07-18   Start Trial UNIVERSITY HEALTH NETWORK (Toronto, CA) 2033-01-31 RX search
Centocor Ortho Biotech Inc SIMPONI golimumab INJECTABLE; INJECTION 125289 001 2009-04-24   Start Trial UNIVERSITY HEALTH NETWORK (Toronto, CA) 2033-01-31 RX Orphan search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31   Start Trial UNIVERSITY HEALTH NETWORK (Toronto, CA) 2033-01-31 RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31   Start Trial UNIVERSITY HEALTH NETWORK (Toronto, CA) 2033-01-31 RX search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Start Trial UNIVERSITY HEALTH NETWORK (Toronto, CA) 2033-01-31 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKesson
Boehringer Ingelheim
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.